113 related articles for article (PubMed ID: 26072410)
1. Use of GLV-1h68 for Vaccinia Virotherapy and Monitoring.
Frentzen A; Geissinger U; Tsoneva D; Stritzker J
Methods Mol Biol; 2015; 1317():225-37. PubMed ID: 26072410
[TBL] [Abstract][Full Text] [Related]
2. Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.
Zhang Q; Yu YA; Wang E; Chen N; Danner RL; Munson PJ; Marincola FM; Szalay AA
Cancer Res; 2007 Oct; 67(20):10038-46. PubMed ID: 17942938
[TBL] [Abstract][Full Text] [Related]
3. Vaccinia virus GLV-1h237 carrying a Walker A motif mutation of mouse Cdc6 protein enhances human breast tumor therapy in mouse xenografts.
Hofmann E; Grummt F; Szalay AA
Int J Oncol; 2011 Mar; 38(3):871-8. PubMed ID: 21249314
[TBL] [Abstract][Full Text] [Related]
4. Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma.
Kelly KJ; Woo Y; Brader P; Yu Z; Riedl C; Lin SF; Chen N; Yu YA; Rusch VW; Szalay AA; Fong Y
Hum Gene Ther; 2008 Aug; 19(8):774-82. PubMed ID: 18754710
[TBL] [Abstract][Full Text] [Related]
5. Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68.
Gentschev I; Müller M; Adelfinger M; Weibel S; Grummt F; Zimmermann M; Bitzer M; Heisig M; Zhang Q; Yu YA; Chen NG; Stritzker J; Lauer UM; Szalay AA
PLoS One; 2011; 6(7):e22069. PubMed ID: 21779374
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68.
Ehrig K; Kilinc MO; Chen NG; Stritzker J; Buckel L; Zhang Q; Szalay AA
J Transl Med; 2013 Mar; 11():79. PubMed ID: 23531320
[TBL] [Abstract][Full Text] [Related]
7. Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68.
Gentschev I; Donat U; Hofmann E; Weibel S; Adelfinger M; Raab V; Heisig M; Chen N; Yu YA; Stritzker J; Szalay AA
J Biomed Biotechnol; 2010; 2010():489759. PubMed ID: 20379368
[TBL] [Abstract][Full Text] [Related]
8. Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.
Chen NG; Yu YA; Zhang Q; Szalay AA
J Transl Med; 2011 Sep; 9():164. PubMed ID: 21951588
[TBL] [Abstract][Full Text] [Related]
9. Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma.
Pugalenthi A; Mojica K; Ady JW; Johnsen C; Love D; Chen NG; Aguilar RJ; Szalay AA; Fong Y
Cancer Gene Ther; 2015 Dec; 22(12):591-6. PubMed ID: 26584530
[TBL] [Abstract][Full Text] [Related]
10. Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68.
Yu YA; Galanis C; Woo Y; Chen N; Zhang Q; Fong Y; Szalay AA
Mol Cancer Ther; 2009 Jan; 8(1):141-51. PubMed ID: 19139123
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic vaccinia therapy of squamous cell carcinoma.
Yu Z; Li S; Brader P; Chen N; Yu YA; Zhang Q; Szalay AA; Fong Y; Wong RJ
Mol Cancer; 2009 Jul; 8():45. PubMed ID: 19580655
[TBL] [Abstract][Full Text] [Related]
12. Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-α signaling.
Kyula JN; Khan AA; Mansfield D; Karapanagiotou EM; McLaughlin M; Roulstone V; Zaidi S; Pencavel T; Touchefeu Y; Seth R; Chen NG; Yu YA; Zhang Q; Melcher AA; Vile RG; Pandha HS; Ajaz M; Szalay AA; Harrington KJ
Oncogene; 2014 Mar; 33(13):1700-12. PubMed ID: 23624923
[TBL] [Abstract][Full Text] [Related]
13. Vaccinia virus-mediated intra-tumoral expression of matrix metalloproteinase 9 enhances oncolysis of PC-3 xenograft tumors.
Schäfer S; Weibel S; Donat U; Zhang Q; Aguilar RJ; Chen NG; Szalay AA
BMC Cancer; 2012 Aug; 12():366. PubMed ID: 22917220
[TBL] [Abstract][Full Text] [Related]
14. Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a β-galactosidase-activatable prodrug seco-analog of duocarmycin SA.
Seubert CM; Stritzker J; Hess M; Donat U; Sturm JB; Chen N; von Hof JM; Krewer B; Tietze LF; Gentschev I; Szalay AA
Cancer Gene Ther; 2011 Jan; 18(1):42-52. PubMed ID: 20829890
[TBL] [Abstract][Full Text] [Related]
15. Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice.
Hofmann E; Weibel S; Szalay AA
J Transl Med; 2014 Jul; 12():197. PubMed ID: 25030093
[TBL] [Abstract][Full Text] [Related]
16. A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers.
Haddad D; Chen N; Zhang Q; Chen CH; Yu YA; Gonzalez L; Aguilar J; Li P; Wong J; Szalay AA; Fong Y
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S665-74. PubMed ID: 22258815
[TBL] [Abstract][Full Text] [Related]
17. Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent.
Gentschev I; Stritzker J; Hofmann E; Weibel S; Yu YA; Chen N; Zhang Q; Bullerdiek J; Nolte I; Szalay AA
Cancer Gene Ther; 2009 Apr; 16(4):320-8. PubMed ID: 18949014
[TBL] [Abstract][Full Text] [Related]
18. Effective oncolytic vaccinia therapy for human sarcomas.
He S; Li P; Chen CH; Bakst RL; Chernichenko N; Yu YA; Chen N; Szalay AA; Yu Z; Fong Y; Wong RJ
J Surg Res; 2012 Jun; 175(2):e53-60. PubMed ID: 22341347
[TBL] [Abstract][Full Text] [Related]
19. Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody.
Patil SS; Gentschev I; Adelfinger M; Donat U; Hess M; Weibel S; Nolte I; Frentzen A; Szalay AA
PLoS One; 2012; 7(10):e47472. PubMed ID: 23091626
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic vaccinia virus therapy of salivary gland carcinoma.
Chernichenko N; Linkov G; Li P; Bakst RL; Chen CH; He S; Yu YA; Chen NG; Szalay AA; Fong Y; Wong RJ
JAMA Otolaryngol Head Neck Surg; 2013 Feb; 139(2):173-82. PubMed ID: 23429949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]